Researchers in the Nanoscience Center at the University of Jyväskylä, Finland, have developed a pioneering computational ...
A generalizable ML framework predicts protein interactions with ligand-stabilized gold nanoclusters, supporting faster design ...
Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...
News-Medical.Net on MSN
mRNA therapy rejuvenates immune function in aging mice
Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ ...
PRISM BioLab, Co. Ltd. ('PRISM') and Talus Bioscience, Inc. ('Talus Bio') announced today that they entered into a collaboration to discover novel Inhibitors of transcription factor (TF) and ...
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrol ...
Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRISM BioLab Co., Ltd. (“PRISM”) to accelerate the discovery and ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback